BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2309824)

  • 1. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma.
    Wilson TO; Podratz KC; Gaffey TA; Malkasian GD; O'Brien PC; Naessens JM
    Am J Obstet Gynecol; 1990 Feb; 162(2):418-23; discussion 423-6. PubMed ID: 2309824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment failure in endometrial carcinoma.
    Burke TW; Heller PB; Woodward JE; Davidson SA; Hoskins WJ; Park RC
    Obstet Gynecol; 1990 Jan; 75(1):96-101. PubMed ID: 2296431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I endometrial adenocarcinoma: treatment results in 835 patients.
    Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W
    Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and recurrent patterns in Stage I endometrial cancer.
    DiSaia PJ; Creasman WT; Boronow RC; Blessing JA
    Am J Obstet Gynecol; 1985 Apr; 151(8):1009-15. PubMed ID: 3985062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.
    Mendivil A; Schuler KM; Gehrig PA
    Cancer Control; 2009 Jan; 16(1):46-52. PubMed ID: 19078929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profile.
    Fanning J; Evans MC; Peters AJ; Samuel M; Harmon ER; Bates JS
    Gynecol Oncol; 1989 Mar; 32(3):288-91. PubMed ID: 2920949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients.
    Aalders JG; Abeler V; Kolstad P
    Gynecol Oncol; 1984 Jan; 17(1):64-74. PubMed ID: 6693053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
    Kadar N; Homesley HD; Malfetano JH
    Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
    Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage II cancer of the endometrium: a pathologic and clinical study.
    Wallin TE; Malkasian GD; Gaffey TA; O'Brien PC; Fountain KS
    Gynecol Oncol; 1984 May; 18(1):1-17. PubMed ID: 6714798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases.
    Lee KR; Belinson JL
    Gynecol Oncol; 1992 Jul; 46(1):51-4. PubMed ID: 1634141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium.
    Lurain JR; Rumsey NK; Schink JC; Wallemark CB; Chmiel JS
    Obstet Gynecol; 1989 Aug; 74(2):175-9. PubMed ID: 2748053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of histologic grade in stage II endometrial carcinoma.
    Goplerud DR; Belgrad R
    Surg Gynecol Obstet; 1979 Mar; 148(3):406-8. PubMed ID: 419444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
    McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
    Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors.
    Bucy GS; Mendenhall WM; Morgan LS; Chafe WE; Wilkinson EJ; Marcus RB; Million RR
    Gynecol Oncol; 1989 Jun; 33(3):290-5. PubMed ID: 2722051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of peritoneal cytology in endometrial carcinoma.
    Harouny VR; Sutton GP; Clark SA; Geisler HE; Stehman FB; Ehrlich CE
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):394-8. PubMed ID: 3405555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.